Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells
<p>Abstract</p> <p>Background</p> <p>Drug resistance is a major concern in cancer therapy. Here, we investigate the clinical potential of the second mitochondria-derived activator of caspase (Smac/DIABLO) in enhancing the apoptosis-inducing potential of commonly used anticancer drugs (paclitaxel, do...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2008-06-01
|
| Серии: | Molecular Cancer |
| Online-ссылка: | http://www.molecular-cancer.com/content/7/1/60 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|